Skip to main content
ROHTO PHARMACEUTICAL CO.,LTD. logo

ROHTO PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4527 ISIN · JP3982400008 LEI · 353800Q1CW5OS81OUM12 T Manufacturing
Open in API
Filings indexed 74 across all filing types
Latest filing 2026-05-29 M&A Activity
Country JP Japan
Listing T 4527

About ROHTO PHARMACEUTICAL CO.,LTD.

https://www.rohto.co.jp/global/

Rohto Pharmaceutical Co., Ltd. is a multinational company that manufactures and markets a wide range of health and beauty care products. The company's core business areas are over-the-counter (OTC) pharmaceuticals and skincare. It is a recognized leader in the eye care market, particularly known for its extensive line of eye drops. The product portfolio also includes skincare, oral medications, and functional foods. Rohto Pharmaceutical focuses on research and development to create innovative products and services that support the physical and mental well-being of consumers worldwide, aiming to contribute to the future potential of society through health.

Recent filings

Filing Released Lang Actions
Thann Oryza Co., Ltd. の株式取得完了に関するお知らせ
M&A Activity Classification · 85% confidence The document is a company announcement (“お知らせ”) that Rohto Pharmaceutical has completed an acquisition of shares in Thann Oryza Co., Ltd., making it a subsidiary. This is a merger and acquisition event announcement, fitting the M&A Activity category rather than a full merger proxy or SEC filing. Therefore, it classifies as M&A Activity (Code: TAR).
2026-05-29 Japanese
2032年満期ユーロ円建転換社債型新株予約権付社債の転換価額の調整に関するお知らせ
Capital/Financing Update Classification · 85% confidence The document is an announcement by Rohto Pharmaceutical Co. concerning the adjustment of the conversion price for its 2032-maturity Euro-yen convertible bonds with warrants. It details the old and new conversion prices, the effective date, and the adjustment rationale tied to the dividend decision by the board. This is a financing activity that alters the company’s capital structure, fitting the “Capital/Financing Update (CAP)” category.
2026-05-21 Japanese
剰余金の配当に関するお知らせ
Notice of Dividend Amount Classification · 90% confidence The document is a board resolution notice specifying the per-share dividend amount, record date, total dividend amount, effective date, and source of dividends for the fiscal period ending March 31, 2026. It provides dividend details and payment schedule, matching the definition of a Notice of Dividend Amount (DIV).
2026-05-21 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 95% confidence The document is titled “自己株券買付状況報告書” under the Financial Instruments and Exchange Act, detailing the company’s own share repurchase status (dates, amounts, totals). This matches the definition of “Transaction in Own Shares” (share buyback/issuance report).
2026-05-11 Japanese
株主提案に関する書面受領のお知らせ
Regulatory Filings
2026-04-30 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 96% confidence The document is titled “自己株券買付状況報告書” and cites Financial Instruments and Exchange Act Article 24-6, describing details of share repurchase (number of shares, acquisition period, progress, and holdings). This is a regulatory report on the company’s own share transactions (share buyback). According to the classification rules, this falls under Transaction in Own Shares (Code: POS).
2026-04-20 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.